Trennda Rittenbach, OD
Optometrist · Sunnyvale
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Rittenbach’s office at (408) 524-5900 to ask if they take your plan before you enroll.
Medicaid work
$486 in 2019
Medicaid paid $486 for 13 billed services this clinician did in 2019, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 13 | $486 |
| 2019 | 13 | 1 | 13 | $486 |
Drugs they prescribed that Part D paid
$4,175
Pharmacies billed $4,175 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 18) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
0 generic and 12 brand-name prescriptions · $4,175 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 18 | None | 0% (0) | 67% | $4,175 |
| 2023 | 205 | 70 | 0% (0) | 72% | $66,817 |
| 2022 | 831 | 196 | 0% (0) | 61% | $179,574 |
| 2021 | 1,108 | 278 | 0% (0) | 55% | $203,330 |
| 2020 | 885 | 219 | 0% (0) | 51% | $171,040 |
| 2019 | 924 | 237 | 0% (0) | 43% | $163,270 |
| 2018 | 805 | 214 | 0% (0) | 52% | $150,491 |
| 2017 | 559 | 164 | 0% (0) | 58% | $104,176 |
| 2016 | 475 | 146 | 0% (0) | 55% | $85,820 |
| 2015 | 240 | 98 | 0% (0) | 49% | $28,547 |
| 2014 | 36 | 16 | 0% (0) | None | $1,301 |
| 2013 | 18 | None | 0% (0) | None | $641 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Restasis | 11 | $14,301 | $1,300 |
| Lumigan | 19 | $9,894 | $521 |
| Travoprost | 18 | $5,191 | $288 |
| Latanoprost | 78 | $2,886 | $37 |
| Dorzolamide-Timolol | 14 | $311 | $22 |
2022: 12 drugs
| Restasis | 49 | $47,738 | $974 |
| Lumigan | 61 | $29,903 | $490 |
| Travoprost | 60 | $16,821 | $280 |
| Latanoprost | 352 | $11,971 | $34 |
| Vyzulta | 14 | $7,035 | $503 |
| Alphagan P | 11 | $6,591 | $599 |
| Brinzolamide | 11 | $2,945 | $268 |
| Dorzolamide-Timolol | 83 | $2,134 | $26 |
| Brimonidine | 20 | $2,124 | $106 |
| Dorzolamide | 16 | $892 | $56 |
| Timolol Maleate | 31 | $572 | $18 |
| Erythromycin | 15 | $163 | $11 |
2021: 16 drugs
| Restasis | 64 | $64,844 | $1,013 |
| Lumigan | 49 | $23,903 | $488 |
| Travoprost | 53 | $16,986 | $320 |
| Latanoprost | 449 | $16,690 | $37 |
| Cequa | 19 | $14,030 | $738 |
| Rhopressa | 17 | $10,985 | $646 |
| Vyzulta | 16 | $8,843 | $553 |
| Azopt | 13 | $6,907 | $531 |
| Combigan | 12 | $4,148 | $346 |
| Simbrinza | 14 | $3,861 | $276 |
| Brimonidine | 44 | $3,720 | $85 |
| Dorzolamide-Timolol | 91 | $2,812 | $31 |
| Olopatadine | 59 | $2,559 | $43 |
| Dorzolamide | 23 | $1,487 | $65 |
| Erythromycin | 60 | $803 | $13 |
| Timolol Maleate | 44 | $433 | $10 |
2020: 14 drugs
| Restasis | 50 | $51,411 | $1,028 |
| Travoprost | 51 | $15,340 | $301 |
| Latanoprost | 400 | $14,172 | $35 |
| Cequa | 18 | $11,958 | $664 |
| Lumigan | 24 | $11,581 | $483 |
| Azopt | 15 | $10,670 | $711 |
| Rhopressa | 16 | $8,004 | $500 |
| Travatan Z | 13 | $7,216 | $555 |
| Dorzolamide-Timolol | 93 | $4,705 | $51 |
| Brimonidine | 38 | $4,534 | $119 |
| Simbrinza | 15 | $4,110 | $274 |
| Alphagan P | 14 | $3,954 | $282 |
| Timolol Maleate | 31 | $504 | $16 |
| Erythromycin | 21 | $282 | $13 |
2019: 16 drugs
| Restasis | 34 | $39,913 | $1,174 |
| Travatan Z | 66 | $28,388 | $430 |
| Lumigan | 30 | $14,277 | $476 |
| Latanoprost | 385 | $12,690 | $33 |
| Xiidra | 13 | $12,004 | $923 |
| Rhopressa | 19 | $9,469 | $498 |
| Azopt | 16 | $7,248 | $453 |
| Dorzolamide-Timolol | 102 | $6,832 | $67 |
| Alphagan P | 15 | $4,243 | $283 |
| Combigan | 13 | $3,286 | $253 |
| Brimonidine | 34 | $3,266 | $96 |
| Dorzolamide | 29 | $1,528 | $53 |
| Olopatadine | 21 | $983 | $47 |
| Timolol Maleate | 31 | $691 | $22 |
| Valacyclovir | 15 | $617 | $41 |
| Erythromycin | 33 | $458 | $14 |
2018: 15 drugs
| Restasis | 36 | $39,053 | $1,085 |
| Travatan Z | 63 | $23,781 | $377 |
| Azopt | 29 | $12,567 | $433 |
| Lumigan | 32 | $11,191 | $350 |
| Latanoprost | 300 | $10,463 | $35 |
| Zioptan | 12 | $5,542 | $462 |
| Alphagan P | 21 | $3,600 | $171 |
| Simbrinza | 15 | $2,640 | $176 |
| Dorzolamide-Timolol | 60 | $2,250 | $37 |
| Timolol Maleate | 46 | $2,164 | $47 |
| Brimonidine | 27 | $1,716 | $64 |
| Olopatadine | 21 | $1,149 | $55 |
| Dorzolamide | 20 | $977 | $49 |
| Valacyclovir | 13 | $639 | $49 |
| Erythromycin | 27 | $309 | $11 |
2017: 11 drugs
| Restasis | 38 | $35,268 | $928 |
| Travatan Z | 66 | $19,463 | $295 |
| Lumigan | 31 | $8,707 | $281 |
| Latanoprost | 176 | $6,135 | $35 |
| Azopt | 12 | $4,313 | $359 |
| Simbrinza | 22 | $3,759 | $171 |
| Brimonidine | 22 | $2,628 | $119 |
| Timolol Maleate | 38 | $1,689 | $44 |
| Dorzolamide-Timolol | 20 | $793 | $40 |
| Dorzolamide | 29 | $761 | $26 |
| Erythromycin | 12 | $145 | $12 |
2016: 11 drugs
| Restasis | 56 | $38,972 | $696 |
| Travatan Z | 37 | $10,347 | $280 |
| Lumigan | 22 | $6,988 | $318 |
| Azopt | 14 | $5,230 | $374 |
| Combigan | 11 | $4,898 | $445 |
| Latanoprost | 126 | $3,017 | $24 |
| Simbrinza | 12 | $1,708 | $142 |
| Tobramycin-Dexamethasone | 20 | $1,488 | $74 |
| Timolol Maleate | 28 | $686 | $25 |
| Dorzolamide | 13 | $325 | $25 |
| Erythromycin | 22 | $251 | $11 |
2015: 6 drugs
| Restasis | 18 | $11,792 | $655 |
| Lotemax | 11 | $1,912 | $174 |
| Latanoprost | 66 | $1,371 | $21 |
| Tobramycin-Dexamethasone | 14 | $1,141 | $81 |
| Timolol Maleate | 16 | $848 | $53 |
| Erythromycin | 14 | $204 | $15 |
2014: 1 drug
| Latanoprost | 15 | $410 | $27 |
Money from drug and device companies
$11 in 2021
| 2021 | 1 | 1 | None | $11 |
| 2020 | 1 | 1 | None | $14 |
| 2019 | 1 | 1 | None | $120 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Allergan | Restasis Multidose | $11 | 1 payment
|
See the published payment
| Allergan | Meals · 2021-03-23 | Restasis Multidose | $11 |
See earlier years (2020, 2019)
2020: $14
| Allergan | Lumigan | $14 | 1 payment
|
2019: $120
| Sun Pharmaceutical Industries | Cequa | $120 | 1 payment
|
Professional record
- NPI
- 1427207497
- Licence
- CA OPT15049, MN 3156
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 152W00000X (152W00000X)
- Mailing address
- 2350 W. El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2008-09-15
- NPI last updated
- 2015-04-13
This is when the NPI record was last certified, not a medical board exam.